The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.

Guests

  • Dr. Paul Antony chief medical officer for the Pharmaceutical Research and Manufacturers of America
  • Dr. Janet Woodcock deputy commissioner and chief medical officer of the FDA
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows